Key result
Mechanical right heart support in LVAS is linked to ~4.7-fold higher mortality.
Observational (n=106)
No
Answers are grounded in this paper and cite their sources.
BACKGROUND: This study was designed to elucidate the key factors for successful long-term support with a left ventricular assist system (LVAS) in the situation where heart transplantation is rarely available. METHODS AND RESULTS: From 1992 to 2008, 106 patients underwent 121 LVAS implantations at Osaka University Hospital (Toyobo: 77; Novacor: 18; HeartMate: 14; Jarvik2000: 8; EvaHeart: 2; DuraHeart: 2). Risk factors for infection were early on the former implanted period (odds ratio (OR) 3.30), Toyobo (OR 2.25), mechanical right heart support (OR 2.30) and cardiopulmonary bypass time (OR 1.01). Left atrium as the inflow site was the risk factor for cerebrovascular events (OR 2.84). Older age (OR 1.04) and mechanical right heart support (OR 4.70) were risk factors for mortality. Risk factors for requiring mechanical right heart support were preoperative extracorporeal membranous oxygenation support (OR 5.641), serum total bilirubin (OR 1.11) and serum creatinine (OR 2.46). On the basis of the risk analysis for mortality, patients were divided into 2 subgroups (low and high risk) and the respective cumulative survival at 1 year after LVAS implantation was 75.2% and 25.0%. CONCLUSIONS: Appropriate selection of device, patient and the timing of implantation and less invasive operation are important for successful long-term LVAS support.
No takes yet. Share an insight, caveat, or question.
Saito et al. (2010) conducted an observational in Patients requiring long-term left ventricular assist system (LVAS) support (n=106). Mechanical right heart support and older age in LVAS patients (high-risk vs low-risk subgroup) vs. Absence of mechanical right heart support / low-risk subgroup was evaluated on Mortality and 1-year cumulative survival after LVAS implantation (OR 4.70). In LVAS patients, older age and mechanical right heart support predicted mortality, yielding 1-year survival of 75.2% in low-risk vs 25.0% in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: